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Astrud R Tuck1,2, Rebecca L Robker1, Robert J Norman1, Wayne D Tilley2 and Theresa E Hickey1,2*Abstract
Background: The c-kit/kit ligand (KITL) signalling axis is an essential component of ovarian folliculogenesis in
mammals, but little is known about expression and localisation of its key components in the ovaries of reproductive
age women. This study aimed to characterise mRNA expression of c-kit and KITL isoforms and the localisation of c-kit
and KITL proteins in adult human premenopausal ovaries.
Methods: This study utilised granulosa cells obtained from the preovulatory follicles of women undergoing assisted
reproduction, pieces of ovarian tissue obtained from premenopausal women undergoing gynaecological surgeries and
archival paraffin-embedded premenopausal ovarian tissues. Methodology included PCR for gene expression and Western
blot or immunohistochemistry for protein expression.
Results: Both c-kit mRNA isoforms, known as GNNK+ and GNNK-, were detected in human ovarian cortex, while KITL
protein isoforms (KITL1 and KITL2) were present in ovarian cortex and human granulosa cells. Immunohistochemistry
showed expression of KITL and c-kit protein in multiple cell types within follicles throughout development,
from primordial follicles to large antral follicles, in addition to atretic follicles. Oocytes of all follicle stages
expressed c-kit protein exclusively. Interestingly, unlike animal models, expression of both proteins displayed a
less cell-type specific distribution with immunostaining present in granulosa, theca and stromal cells, suggesting that
autocrine signalling occurs within the human ovary.
Conclusion: The results of this study indicate that c-kit/KITL signalling also occurs in the human ovary, as established in
various animal models, and may involve previously unknown autocrine signalling.
Keywords: Human, Ovarian follicles, c-kit, KITL, Immunohistochemistry, Granulosa, Theca, PCOSBackground
KITL is a cytokine growth factor secreted by granulosa
cells of ovarian follicles that exerts intra-follicular
paracrine signals via stimulation of the c-kit receptor,
which is expressed in theca cells and oocytes [1–3].
Transgenic mouse models have been utilised to demon-
strate critical roles for the key ligand and receptor
components of the c-kit/KITL signalling pathway during
folliculogenesis ([4–8]; 2004). Expression and function of
these key components have also been elucidated in other
animal models including rat, rabbit, chicken, goat, pig
and cow [1, 2, 9–11], and these have demonstrated
several key roles that are essential for the maintenance* Correspondence: theresa.hickey@adelaide.edu.au
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creativecommons.org/publicdomain/zero/1.0/of ovarian function and fertility. These roles include
primordial follicle activation, promotion of primary to
secondary follicle transition, preantral follicle growth,
formation of the theca layer, thecal steroidogenesis and
anti-apoptosis [3, 9].
Few studies have examined the expression and func-
tion of c-kit and KITL in human ovarian tissues.
Evidence suggests that while c-kit/KITL signalling does
not appear to be involved in human primordial follicle
activation [12], it may have roles in follicle survival and
thecal steroidogenesis similar to animal models.
Currently, consensus is lacking over the cell type
distribution of these two signalling proteins in human
ovarian tissues [12–14], which hampers understanding
of their role in human ovarian function. Differences
among studies may be largely due to the detection
methodologies employed and the difficulty of obtainingle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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make conclusive observations. In one study, expression of
KITL was found to be detected only in the oocytes of fetal
and adult ovaries [14], a finding which is in stark contrast
to animal studies where KITL protein is localised exclu-
sively to granulosa cells. For c-kit expression, one study
demonstrated the presence of c-kit protein on the mem-
branes and cytoplasm of preantral granulosa cells of adult
human ovaries [12], while another study reported the
presence of c-kit protein only in the oocytes of preantral
follicles [14]. These data that confine c-kit expression to
the preantral follicle cohort are not consistent with the
detection of soluble c-kit protein in the follicular fluid of
antral follicles [13]. The latter finding suggests that the
theca layer secretes soluble c-kit into the follicular fluid,
although this remains to be confirmed. Inconsistencies in
previous studies involving human ovarian tissues highlight
the need for a more comprehensive study into the ex-
pression of the c-kit/KITL signalling pathway to reveal
potential species differences.
Polycystic ovary syndrome (PCOS) is a common endo-
crine disorder associated with infertility and metabolic
morbidities [15, 16]. Polycystic ovaries (PCO) are signifi-
cantly enlarged, fibrotic, and contain an increased num-
ber of antral follicles in a state of developmental arrest.
Although the specific roles of c-kit and KITL in the hu-
man ovary have not been established, based on their
established roles in animal models perturbed KITL sig-
nalling could feasibly contribute to multiple phenotypic
characteristics of PCO such as abnormal oocyte growth,
increased follicle and stromal density, thecal hyper-
trophy, and increased thecal cell androgen biosynthesis
[15, 17–22]. To date, the c-kit/KITL signalling system
has not been examined in relation to PCO or PCOS, in
part because it is extremely difficult to obtain normal
pre-menopausal ovarian tissues for comparison.
Numerous isoforms of KITL and c-kit have been de-
scribed in the tissues of various animal species. In terms
of KITL, most species, including humans, express two
isoforms (KITL1 and KITL2) that arise via alternative
mRNA splicing of the KITL gene. The chicken is
uniquely reported to express six KITL isoforms in the
ovary [23]. Two c-kit isoforms, known as GNNK+ and
GNNK-, also arise by mRNA splicing and differ only by
the presence or absence of four amino acids (GNNK) in
the translated protein. These c-kit isoforms have been
detected in the bovine ovary, but their expression in the
reproductive tissues of other species remains unex-
plored. Animal studies have demonstrated the presence
of KITL isoforms within the ovary, and mouse models
have indicated the essential role of KITL2 for oocyte
growth and survival [24]. To date, no study has ever
comprehensively examined KITL or c-kit isoform ex-
pression in the human ovary.To address current gaps in knowledge about the
KITL/c-kit signalling pathway in the ovaries of repro-
ductive age women, the specific aims for this study were
to characterise the mRNA expression of c-kit and KITL
isoforms and to localise c-kit and KITL protein in adult
premenopausal human ovarian tissues, including ovarian
tissues from women clinically diagnosed PCOS. This
study demonstrates the presence of the KITL and c-kit
protein throughout folliculogenesis in a less cell-type
specific distribution than animal follicles. Furthermore,
this study shows for the first time that KITL and c-kit
isoforms are expressed in human ovarian tissue.Materials and methods
Human ovarian tissue collection
Archival ovarian tissue
Formalin-fixed, paraffin-embedded ovarian tissues were
obtained from hospital archives originally owned and
operated by the Institute of Medical and Veterinary
Science (IMVS; Adelaide, South Australia) under ethics
approvals from the Royal Adelaide Hospital, the Central
Northern Adelaide Health Service, and the University of
Adelaide. Records corresponding to premenopausal
women who had surgery for benign gynaecological con-
ditions were collated and the associated tissue blocks
were retrieved where possible. Fourteen tissues were
collected and histologically assessed by a pathologist.
Of these, six had histologically normal morphology
and eight had morphology characteristic of polycystic
ovaries (PCO), two of which had diagnoses of PCOS
in the clinical notes. The mean age of non-PCOS pa-
tients was 35.5 years, while the mean age of PCOS
patients was 37 years. Due to the limited information
contained in the clinical notes of archival tissue, BMI
was not available.
Within ovarian tissues, follicle classifications were per-
formed as follows: a follicle was classified as primordial
if it consisted of an oocyte surrounded by a single layer
of flattened granulosa cells, and classified as primary if
the oocyte was surrounded by a single layer of cuboidal
granulosa cells. A secondary follicle had two or more
layers of granulosa cells without an antrum, and an an-
tral follicle had a large cavity, several layers of granulosa
cells and a defined basal lamina and thecal layer. Large
antral atretic follicles were classified by having an oocyte
with an irregular membrane or a thinning layer of
granulosa cells with pyknotic nuclei. Stages of atresia
were assessed by the level of degradation of the granu-
losa cell layer and the appearance and definition of the
basal lamina and theca layer. Germinal inclusion cysts
were classified as fluid-filled cavities of various sizes
situated in the cortex, surrounded by one or more layers
of cuboidal or rectangular epithelial cells.
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Fresh pieces of human ovarian cortex approximately
1 cm3 in size were obtained from consenting premeno-
pausal (n = 3) women having oophorectomy as part of
gynaecological surgery at the Royal Adelaide Hospital,
South Australia, Australia. The study was approved by
the ethics committees of the Royal Adelaide Hospital
and the University of Adelaide. Tissue was immediately
snap frozen upon collection and stored in liquid nitrogen.
Human granulosa cells
Following informed consent, mural granulosa cells (MGC)
and cumulus granulosa cells (CGC) from pre-ovulatory
follicles were collected from women (n = 4) who were
receiving assisted reproduction at Repromed (Dulwich,
South Australia). The study was approved by the ethics
committees of the Women’s and Children’s Hospital, the
University of Adelaide, and Repromed. All women
underwent a standard hyperstimulation protocol with
gonadotropin-releasing hormone (GnRH) down-regulation
and subsequent gonadotrophin stimulation prior to oocyte
retrieval. Cumulus-oocyte complexes were collected by
transvaginal aspiration. MGCs were isolated by centrifuga-
tion of follicular fluid, mixed with PBS and layered onto
onto a 50:50 v/v mixture of Percoll (Amersham Biosciences,
Australia). After centrifugation to produce a density
gradient, MGCs were removed and subjected to a second
density gradient to remove any remaining blood contamin-
ation. Cells were washed in PBS and then pooled from all
follicular aspirates representing one patient. Cumulus gran-
ulosa cells were removed from the oocyte by manually
trimming (in vitro fertilisation) or hyaluronidase treatment
(intracytoplasmic sperm injection). All cells were snap
frozen and stored at −80 °C.
RNA isolation
Total RNA was extracted from cells using RNeasy Micro
Kit (Qiagen, Hilden, Germany) with on-column DNase
treatment (RNase-Free DNase Set, Qiagen) and RNA
yield was assessed by spectrophotometer (ND-1000;
NanoDrop Technologies Inc, Wilmington, DE, USA).
Reverse transcription was performed on 100 ng of total
RNA using the iScript First-Strand cDNA Synthesis Kit
(Bio-Rad Laboratories, NSW, Australia).
Polymerase chain reaction
PCR to detect c-kit isoforms was performed using a pri-
mer pair designed to show both isoforms as previously
described [25]: (forward: 5′-GGGGGATCCGATGTGG
GCAAGACTTCT-3′; reverse 5′-CAGCAAAGGAGTG
AACAG-3′). PCR was performed using a Pfu polymerase
(Stratagene, La Jolla, CA, USA) and thermocycler condi-
tions as follows: 94 °C for 7 min, then 25 cycles consisting
of 94 °C for 1 min, 45 °C for 1 min and 72 °C for 12 min.PCR products were visualised on a 4 % agarose gel to
detect products 93 and 81 bp in size (GNNK+ and
GNNK–respectively). cDNA from the human leukaemic
cell line, K562, was obtained from the Leukaemia Unit,
Department of Molecular Pathology (SA Pathology,
Adelaide, South Australia, Australia) and used as posi-
tive control for c-kit expression [26, 27].
Western blot
Human breast tissue was obtained from the Dame Roma
Mitchell Cancer Research Laboratories (University of
Adelaide, South Australia) for use as a positive control
for c-kit immunostaining. Frozen ovarian cortex or fro-
zen breast tissue, approximately 1 cm3, was ground to a
fine powder using a mortar and pestle. Liquid nitrogen
ensured that samples remained frozen at all times.
Breast, ovarian cortex, MGC and CGC were lysed using
RIPA buffer including protease inhibitor cocktail tablets,
followed by centrifugation at 10,000 rpm for 10 min at
4 °C. Concentration of protein was determined using a
Bradford protein assay at 595 nM. CCRF-HSB-2, a
human leukaemic cell lysate, was commercially obtained
for use as a positive control for c-kit (Santa Cruz
Biotechnology, Santa Cruz, CA, USA) as previously
demonstrated [28] and used according to the sup-
plier’s instructions.
Protein samples were prepared by adding 6x loading
dye, denaturing at 100 °C for 5 min then centrifuging
for 1 min. Proteins (20 μg) were electrophoresed on
Criterion XT precast gels in 1x XT MOPS running
buffer at 150 V for a total running time of 60–90 min.
Precision Plus Protein Standards Dual Colour molecu-
lar weight marker was run alongside protein samples.
Proteins were transferred to a Hybond-C nitrocellulose
membrane under wet transfer conditions, using a
Criterion Blotter according to the manufacturer’s
instructions. Briefly, the transfer was set up in cold 1x
transfer buffer with the gel and membrane stacked
between Whatman filter paper, and transferred in cold
1x transfer buffer at 400 mA for 60–90 min. Protein
transfer was checked by staining the membrane for
1 min in Ponceau stain, followed by brief rinsing in
TBST. Membranes were blocked in TBST containing
3 % skim milk powder for 1 h, followed by incubation
with either the c-kit primary antibody (1:1000, poly-
clonal rabbit anti-human CD117, DakoCytomation,
Glostrup, Denmark) or the KITL primary antibody
(1:1000; anti-stem cell factor, Millipore, Billerica, MA,
USA) overnight at 4 °C. The appropriate HRP-
conjugated secondary antibody (1:2000) was added for
30 min. Each primary and secondary antibody was
diluted in TBST containing 1 % skim milk powder.
Membranes were washed 3 times for 10 min in TBST
following incubation with each antibody. All steps were
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except for overnight incubations which were per-
formed at 4 °C. Bound antibody was visualised using
SuperSignal West Dura Extended Duration Substrate,
according to the manufacturer’s instructions, and ex-
posed to Amersham Hyperfilm ECL. The film was de-
veloped in a dark room using standard developing and
fixative reagents. Densitometry analysis was performed
by measuring band intensity using the AlphaImager
2200 gel documentation system (Alpha Innotech, San
Leandro, CA, USA).
Immunohistochemistry
A range of c-kit antibodies were tested and optimised
using human ovarian tissue and human gastrointestinal
stromal tumour (GIST) as a positive control (obtained
from IMVS, Adelaide). From these, CD117 rabbit poly-
clonal antibody (DakoCytomation) was chosen as it was
the antibody that provided a pattern of staining in GISTFig. 1 c-kit and KITL isoforms are expressed in human ovary (a) c-kit isofo
three premenopausal women. Human leukaemia cell line K562 which exp
depicting a single 145 kDa band in human ovary and breast tissue lysates
band, representing glycosylated protein, as well as a smaller, 120kD, band rep
the KGN human granulosa tumour cell line as a positive control, mural granu
preantral follicles. Specific bands for KITL1 (36kD) and KITL2 (33kD) are presen
but is absent in KGN cells. (d) Overnight incubation of the KITL antibody withmost similar to that used for diagnosis as shown in pre-
vious studies [29, 30], and had low background staining
in ovarian test sections. This antibody has also been
used in a previous study examining c-kit expression via
immunohistochemistry in adult human ovaries [31]. No
blocking peptide was available to confirm antibody
specificity, but the presence of a single band on Western
blot indicates the antibody is specific (Fig. 1b). Similarly,
a range of KITL antibodies were tested and optimised
using human breast carcinoma as a positive control
(obtained from Dame Roma Cancer Research Laboratories,
Adelaide). The antibody (Cell Signalling Technology, Inc.,
MA, USA) used in this study detects both isoforms as it
was raised against a peptide sequence in the amino
terminus of human KITL that is common to both isoforms,
and this was confirmed in human breast carcinoma (data
not shown). Antibody specificity in human ovarian tissue
and breast carcinoma was confirmed by pre-absorption
with the antigenic peptide (produced by Auspep, VIC,rms, GNNK+ and GNNK−, were both present in ovarian cortex from
resses both isoforms was used as a positive control. (b) Western blot
. CCRF-HSB-2 was used as a positive control and contains the 145kD
resenting non-glycosylated c-kit. (c) KITL protein isoform expression in
losa cells (MGC), cumulus cells (CC) and ovarian cortex containing some
t in all samples. An unknown 29kD band appears in the primary tissues
its specific peptide demonstrates specificity
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ling Technology), which resulted in a complete absence of
staining in all tissue areas.
Immunohistochemistry was performed on tissue sec-
tions (3 μm) as previously described [32], except anti-
gen retrieval in 10 mM citrate buffer (pH 6.5) was
performed using a Decloaking Chamber (Biocare Med-
ical, Concord, CA, USA) following the manufacturer’s
protocol. Quenching of endogenous peroxidise activity
(6 % H2O2 in methanol for 5 min at room temperature)
was performed followed by blocking of non-specific
antigens with 5 % goat serum in PBS for 1 h at room
temperature. Tissues were stained with a 1:300 dilution
of c-kit (CD117) (DakoCytomation, Glostrup, Denmark)
or 1:100 dilution of KITL antibody (Cell Signalling
Technology, Inc., MA, USA) overnight at 4 °C. A differ-
ent KITL primary antibody to the one used for Western
blot was utilised for immunohistochemistry, due to the
Western blot antibody being unsuitable for use in
immunohistochemistry. Visualisation of immunoreac-
tivity was performed using a standard immunoperoxi-
dase reaction. Biotinylated anti-rabbit antibody (1:400),
streptavidin-HRP complex (1:500) and diaminobenzi-
dine tetrahydrochloride was used to generate an insol-
uble brown deposit. Stained sections were scanned
using the NanoZoomer image system (Hamamatsu,
Japan) set at a magnification of 40X.Results
c-kit mRNA and protein expression in human
ovarian cortex
To examine the presence of GNNK c-kit mRNA
isoforms, RT-PCR was performed on mRNA isolated
from ovarian cortical tissue collected from pre-
menopausal women (n = 3) between 40 and 50 years of
age. Haematoxylin and eosin staining was performed
in corresponding tissue sections, which revealed that
several healthy preantral follicles were present within
all the tissues (data not shown). Figure 1a shows the
presence of two distinct PCR products in ovarian
cortical tissue from three different patients as well as
in K562 human leukaemia cells, which correspond to
the GNNK+ (93 bp) and GNNK− (81 bp) isoforms.
Although not quantitative, these results indicate that
human ovarian cortical tissue expresses both mRNA
isoforms of c-kit.
To examine the presence of c-kit protein, ovarian
cortical tissue lysates were assessed by Western blot.
Human leukaemic cell line lysate, CCRF-HSB-2, and
human breast tissue lysate were used as positive controls
since both have previously been shown to express c-kit
[28, 33]. As expected, CCRF-HSB-2 cells possessed c-
kit protein bands of 145 kDa and 120 kDa, thought tobe glycosylated and unglycosylated forms of c-kit, re-
spectively [34, 35]. Note that the GNNK+ and GNNK-
isoforms cannot be distinguished via Western Blot due
to the very small size difference between their corre-
sponding proteins. Ovarian cortex and breast tissue
lysates contained a single 145 kDa band (Fig. 1b), sug-
gesting that unglycosylated forms of c-kit are not
present. The KGN ovarian granulosa tumour cell line
was added as a potential negative control for c-kit pro-
tein, as we were unable to detect mRNA for either c-kit
isoform in this cell line (data not shown).KITL protein isoform expression
To examine KITL protein isoform expression in samples
representative of different stages of follicle development,
Western blot was performed using lysates from: 1) KGN
cells that have a phenotype similar to granulosa cells from
preantral/ early antral follicles [36]; 2) human pre-
menopausal ovarian cortex containing primordial and pre-
antral follicles; 3) mural granulosa cells (MGC) aspirated
from the pre-ovulatory follicles of a women receiving
assisted reproduction and 4) cumulus granulosa cells
(CGC) stripped from the cumulus-oocyte-complexes aspi-
rated from the pre-ovulatory follicles of the same woman.
KGN cells contained both KITL1 and KITL2 protein iso-
forms, detected as 36 kDa and 33 kDa bands as expected.
Lysates derived from primary tissues also expressed both
KITL isoforms to different degrees but an additional
29 kDa band was also consistently present (Fig. 1c). The
Western blot shown is representative of three independ-
ent experiments. These qualitative findings were reprodu-
cible when analysing samples derived from other patients.
Due to the nature of the samples, which represented ei-
ther a whole tissue lysate or distinct enriched populations
of cells, common loading control markers were not appro-
priate use and quantitative comparisons could not be
made among the different samples. However, in general,
levels of KITL2 (33 kDa) appeared proportionally higher
than levels of KITL1 in KGN cells and ovarian cortical
tissue, while levels of KITL1 appeared proportionally
greater than KITL2 in MGC and CGC lysates. To fur-
ther validate the specificity of each band, the KITL pri-
mary antibody was incubated overnight with a KITL
peptide (Auspep, West Melbourne, VIC, Australia).
The 29 kDa band was abolished along with the two
expected KITL isoforms bands following peptide com-
petition (Fig. 1d), suggesting that it is also an isoform
of KITL, albeit one that is larger than the secreted
form of KITL which is known to be approximately
18 kDa in size [9]. Interestingly, Ensembl Human (http://
asia.ensembl.org/Homo_sapiens/Transcript/Summary?
db=core;g=ENSG00000049130;r=12:88492793-88534762;
t=ENST00000378535) includes a transcript of a third KITL
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the 29 kDa band, suggesting that this protein may be a
third isoform. Collectively, these observations suggest that
KITL2 is the predominant isoform expressed during earl-
ier stages of follicle development, while KITL1 is predom-
inantly expressed in the later, preovulatory, stage.
c-kit and KITL expression and localisation throughout
follicle development
To further localise c-kit and KITL protein expression,
human ovarian sections were subjected to immunohisto-
chemistry. The patterns of staining intensities observed
in preantral and antral follicle types are summarised in
Table 1. A human gastrointestinal stromal tumour
(GIST) was used as a positive control for c-kit immuno-
staining (Additional file 1: Figure S1) as this antibody is
routinely used for diagnosis of GIST [29, 30]. Human
breast tissue was used as a positive control for KITL
immunostaining (Additional file 2: Figure S2) and pep-
tide competitions via incubation of the KITL primary
antibody with its specific peptide abolished immunore-
activity in both breast and ovarian tissue (Additional file
2: Figure S2).
In primordial and primary follicles, c-kit immunostain-
ing was present on the oolemma and also present in the
ooplasm of the majority of oocytes (Fig. 2a, c). Some
follicles also showed diffuse cytoplasmic staining in all
granulosa cells surrounding the oocyte. Little to no
staining was observed in the stromal cells surrounding
follicles. KITL immunostaining was weak or absent in
the ooplasm of primordial and primary follicles and in
the cytoplasm of their associated GC (Fig. 2b, d).
Sporadic, weak immunostaining was also observed in
the stroma surrounding these follicles.
Antral follicles showed diffuse, weak cytoplasmic c-kit
staining within granulosa cells and the thecal layer
(Fig. 3a, c). Moderate cytoplasmic KITL staining was
present within all granulosa cells and the thecal layer of
antral follicles (Fig. 3b, d). Weak KITL immunostaining
was present in adjacent stroma. There were no oocytes
present in any of the antral follicles examined.
Immunostaining was also examined in atretic folli-
cles. A follicle in the early stages of atresia with an
intact granulosa layer, basal lamina and theca layer
showed diffuse cytoplasmic c-kit and KITL staining inTable 1 Summary of the patterns of c-kit and KITL staining
intensities observed in preantral and antral follicles
Primordial Primary Antral
OOC GC OOC GC OOC GC TH
c-kit ++/+++ ─/+ ++/+++ ─/+ n/a + +
KITL ─/+ ─/+ ─/+ ─/+ n/a +/++ +/++
- negative; + weak; ++ moderate; +++ strong; n/a none available
OOC, oocyte; GC, granulosa cells; TH; theca layerthe granulosa and theca cells (Fig. 4a, b). In a follicle
with a degrading granulosa layer, c-kit and KITL stain-
ing remained present in the cytoplasm of apoptotic
granulosa cells and theca cells (Fig. 4c, d). KITL and
c-kit immunostaining was present in theca cells and
the few remaining granulosa cells of a follicle with
advanced atresia lacking distinction between the areas
of remaining granulosa cells, basal lamina and theca
layer (Fig. 4e, f ).
c-kit and KITL expression and localisation in ovarian
follicles of women with PCOS
The cohort of ovarian tissues collected included two pa-
tients clinically diagnosed with PCOS. Interestingly,
KITL staining was markedly more intense in granulosa
cells, oocytes and surrounding stroma of follicles at all
stages of development (Fig. 5) compared to follicles in
non-PCOS ovaries (Figs. 2 and 3). While there were no
secondary follicles present in non-PCOS ovaries for
comparison, KITL staining was intense within the oo-
cyte, granulosa cells and surrounding stroma cells of a
secondary follicle present within one of the PCOS tis-
sues (Fig. 5e, f ). While the intensity of c-kit staining ap-
peared no different in the two PCOS ovaries compared
to non-PCOS, it was observed that oocytes in preantral
follicles of PCOS patients more consistently exhibited
strong oolemma staining. Moderate c-kit staining was
present within the oolemma of the secondary follicle,
and diffuse cytoplasmic staining was also present in
granulosa cells and surrounding stroma cells (Fig. 5e, f ).
Granulosa cells of PCOS preantral follicles appeared to
have mostly negative c-kit staining. C-kit immunostain-
ing did not appear visually different in PCOS antral folli-
cles compared to non-PCOS. Although this represents a
small set of observations, the results are suggestive of an
aberrant KITL/c-kit signalling axis in PCOS.
Discussion
This study demonstrates that the c-kit/KITL signalling
pathway is expressed at multiple stages of follicular
development in adult, reproductive age human ovaries.
Moreover, this is the first study to document the
presence of specific c-kit and KITL isoforms in human
ovarian tissue. Their presence in preantral and antral
follicle stages is indicative of their involvement in human
folliculogenesis.
Unlike mouse ovaries, in which c-kit and KITL are
expressed in distinct cellular compartments and signal
exclusively in a paracrine manner, the expression pattern
of c-kit and KITL in human ovaries displayed a less cell-
type specific distribution. Human granulosa, theca and
stromal cells all displayed at least some weak staining
for both proteins, suggesting that autocrine signalling
occurs in these cells types. The presence of c-kit protein
Fig. 2 c-kit and KITL are present in preantral follicles. Representative images of c-kit (a, c) and KITL (b, d) immunostaining in primordial (a, b) and
primary (c, d) follicles. O: oocyte; G: granulosa cells. The open arrow indicates a primordial follicle
Fig. 3 c-kit and KITL are present in antral follicles. Representative images of c-kit (a, c) and KITL (b, d) immunostaining at low (a, b) and
high (c, d) magnifications. A: antrum; G: granulosa cells; T: theca layer; S: stroma
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Fig. 4 c-kit and KITL are expressed during various stages of atresia. (a, b) Intact granulosa layer, theca layer and basal lamina. (c, d) Disassociating
granulosa cell layer with pyknotic nuclei. (e, f) Atretic follicle with little remaining of the granulosa layer and no distinction between the basal
lamina and theca layer. A: antrum; G: granulosa cells; BL: basal lamina; T: theca layer; S: stroma
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which demonstrated the presence of c-kit mRNA and
protein in pregranulosa cells and granulosa cells of
primordial follicles in human fetal ovaries [12, 14, 37].
This finding suggests that the roles of KITL previously
established in animal models may also be present in the
human ovary, and furthermore, that these functions are
perhaps regulated in a differential manner (e.g., autocrine
versus paracrine). Given that KITL promotes preantral
follicle growth and oocyte development [1, 38–40], human
preantral follicles that are positive for granulosa cell c-kit
may possess a selective advantage over follicles that do
not express the KITL receptor.
c-kit and KITL protein was also found to be co-
expressed in the theca layer of all antral follicles. This
suggests that the roles of KITL in formation and func-
tion of the theca layer, as shown in the bovine ovary[41–43], may remain conserved in the human ovary. In
contrast, a study examining c-kit immunostaining in
human adult ovaries did not show any c-kit protein in
the theca layer [12]. This is most likely due to the
primary antibody used, ACK-2, which has been utilised
primarily to inhibit c-kit in in vivo mechanistic studies
rather than for immunohistochemistry. The antibody
used in our study was carefully selected from a range of
antibodies that were extensively tested, and has also
been established in studies to be the most optimal
and accurate antibody for use in diagnosis of GIST
[29, 30]. No blocking peptide was available, but the
presence of a single band on Western blot indicates
the antibody is specific.
This study demonstrated that both KITL and c-kit are
present in granulosa and thecal cells of antral follicles
throughout atresia until cell layers have undergone total
Fig. 5 c-kit and KITL in PCOS preantral and antral follicles. Representative images of primordial follicles (a, b), primary follicles (c, d), secondary
follicles (e, f) and antral follicles (g, h). O: oocyte; G: granulosa cells
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shown to be maintained in the granulosa cells of
atretic follicles [44], while in mice, KITL expression
disappears [5]. This is the first study to demonstrate
the presence of c-kit expression in atretic follicles, and
it is unclear whether the KITL/c-kit system plays an
active role in dying follicles.This study is the first to demonstrate KITL1 and
KITL2 protein expression in human granulosa cell
types. Interestingly, KGN cells, which are representative
of preantral follicles, showed evidence of higher levels
of KITL2 which may suggest a greater role for KITL
during early follicle development. This isoform has
been demonstrated to be crucial for fertility and normal
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oocyte growth and survival in vitro [24]. The anchorage
of KITL2 in the cell membrane is believed to be
responsible for its prolonged receptor activation com-
pared to KITL1, suggesting that KITL2 signalling may
be more efficient and promotes sustained effects [46].
In our study, granulosa cells from preovulatory follicles
showed higher levels of KITL1, which is believed to
initiate shorter-term, transient effects due to faster
receptor internalisation and degradation of the ligand/
receptor complex [46]. Many established roles for KITL
occur during earlier follicle development [9]. The pres-
ence of increased levels of KITL2 in preantral granulosa
cells may suggest that KITL plays a greater or more
prolonged role during early human folliculogenesis.
We also report for the first time that both GNNK+
and GNNK− mRNA isoforms of c-kit are present within
the human premenopausal ovary, but it remains an im-
portant unanswered question which individual cell types
specifically express each isoforms. In NIH3T3 fibroblast
cells, GNNK− causes faster receptor phosphorylation
and internalisation, and more extensive activation of the
MAPK pathway than GNNK+ [25]. The presence of each
isoform in the human ovary may suggest that regulation
of KITL signalling occurs at the receptor level, and is de-
termined by the particular c-kit isoform being expressed.
This may have important implications in ovarian path-
ologies where perturbed c-kit/KITL signalling may play
a role, such as PCOS which is mentioned further below.
This observation, if confirmed in individual cell types,
may provide some knowledge of the mechanisms of
KITL signalling in the human ovary via activation of
specific c-kit isoforms.
A limitation of our study that should be noted was the
inability to quantify the levels of c-kit cDNA and KITL
protein for comparison in each cell and tissue type. As
these experiments were performed on whole tissue
lysates and distinct, isolated cell types, a housekeeping
gene or loading control marker could not be assumed to
have consistent expression across each tissue type.
Furthermore, we did not have the required numbers of
participants to perform rigorous statistical analysis of
expression levels. Thus, our study demonstrates only the
presence of c-kit and KITL isoforms in ovarian tissues
and cell types and is not able make quantitative conclu-
sions on their expression levels.
Interestingly, this study observed markedly increased
KITL immunostaining intensity in follicles at all stages
of development within the two PCOS ovaries that were
examined. Diffuse staining was also present within the
oocytes of all preantral follicles, unlike the follicles of
the morphologically normal ovaries examined in this
study, suggesting altered expression of KITL in PCOS
oocytes. It could be postulated that increased KITLlevels in PCOS ovaries may underlie several of the
abnormalities observed in PCOS, such as increased
ovarian reserve [2, 47–50] or enlarged oocytes [51],
due to the diverse roles KITL has in animal models.
Further study is required to confirm whether KITL
protein is increased in PCOS using a larger sample size
with ovarian tissues corresponding to women with
more extensive clinical documentation for PCOS, in-
cluding relative ovulation frequency.
In conclusion, this study has demonstrated the
presence of KITL and c-kit in the adult human ovary
throughout follicle development, in addition to show-
ing the presence of each isoform. This suggests that
the KITL/c-kit system is involved in human folliculo-
genesis, and further study is required to elucidate their
roles and importance in human follicle development
and fertility.
Additional files
Additional file 1: Figure S1. c-kit immunostaining in human
gastrointestinal stromal tumour (GIST) used as a positive control. (A, B)
Cytoplasmic and membrane staining present in distinct areas. (C) Negative
control consisted of omission of the primary antibody. Arrows indicate cells
with membrane staining.
Additional file 2: Figure S2. KITL immunostaining in human breast and
ovarian tissue. Human breast carcinoma (A-C) and human ovarian cortex
tissue sections (D-F) used as controls for KL immunostaining. (A, D) Positive
KITL staining. (B, E) Negative control which consisted of omission of the
primary antibody. (C, F) Confirmation of KITL antibody specificity by incubation
of the primary antibody overnight with its specific peptide prior to
immunostaining.
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